What amount sold does Sensible Biotechnologies, Inc. report in Form D filings?

The latest linked filings report $15.3M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Sensible Biotechnologies, Inc.'s most recent SEC filing?

Sensible Biotechnologies, Inc.'s most recent Form D filing was on 2026-09-02.

How many investors does Sensible Biotechnologies, Inc. have?

The most recent Form D filing lists 15 investor(s).

What type of securities does Sensible Biotechnologies, Inc. offer?

Sensible Biotechnologies, Inc.'s SEC Form D filings indicate equity offerings.

Sensible Biotechnologies, Inc.

CIK: 0001964363·Biotechnology·Oxford, Oxfordshire, X0·Corporation·Founded 2021

Reported Sold

$15,347,941

Total Filings

Identified Offerings

Last Filed

Sep 2, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Sep 2, 2026Form D — New notice

Reported sold: $13,518,941 · Target: $15,000,000

Rule 506(b)·15 investors

Feb 21, 2023Form D — New notice

Reported sold: $1,829,000 · Target: $3,000,000

Rule 506(b)·18 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$15,347,941

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Miroslav Gasparek

Related Person

Appears on 1 filing

Marian Kupculak

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 2, 2026	New	$15,000,000	$13,518,941	15
Feb 21, 2023	New	$3,000,000	$1,829,000	18

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Pictura Bio US, Inc.

Biotechnology

Offering target: $17,460,598

Filed Sep 25, 2026